仕淨科技(301030.SZ):簽訂潤陽光伏科技(泰國)4GW高效PERC太陽電池生產項目合同
格隆匯11月15日丨仕淨科技(301030.SZ)公佈,公司於2021年9月17日披露了《關於收到項目中標通知書的公吿》,公司中標潤陽光伏科技(泰國)有限公司4GW高效PERC太陽能電池生產項目。
近日,公司與潤陽光伏科技(泰國)有限公司就上述中標項目簽訂了《潤陽光伏科技(泰國)有限公司4GW高效PERC 太陽電池生產項目合同》,合同價格人民幣2億元整(已含泰國段清關7%增值税和關税)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.